OVERVIEW
Alpex Pharma is a pharmaceutical company active in Research & Development and Production of ODT (Orally Dispersible Tablet) called also “fast melt” and effervescent tablets. Alpex Pharma has developed a unique proprietary covering ODT technology.
The high production capacity and advanced R&D technologies makes Alpex Pharma to be one of the most important company of the world in the field of fast melt and effervescent tablets.
The company has a state-of-the-art manufacturing and R&D facilities of some 7000 square meters, with separate pharmaceutical and nutritional plant GMP compliant.
History
- 1988 The company started in 1988 under the name Aesculapius Pharma.
- 1992 In 1992 Aesculapius Pharma was acquired by Elan Corporation PLC and since the acquisition heavy investement have been made in R&D (fast melt technology) and manufacturing facility.
- 1998 The first fast melt nutritional product was commercialised in 1998.
- 2001 The first fast melt pharmaceutical product was commercialised in 2001.
- 2004 In 2004, the majority of capital shares of the company was aquired by funds managed by Sanders Morris Harris, USA, and changed the name to Alpex Pharma
- 2007 Capital increase and entrance of BB Biotech fund in the Alpex’s capital.
Organization
CERTIFICATION
Certificate of GMP compliance
Manufacturing authorization
Certificate of GDP compliance